Evidence map›Paper›PMID 34344808›Full record

ArticleSaudi medical journal2021

Early infection in post-autologous hematopoietic stem cell transplant patients: Princess Noorah Oncology Center experience.

Roaa S Gassas, Ahmed N Absi, Abdulrahman A Alghamdi, Ahmed S Alsaeed, Sameer M Alamoudi, Ihab Y Hemaidi, Majed D Alahmadi, Walaa A Rajkhan, Mannar M Khalil, Saleem K Dadah and 2 more

Abstract read
In one paragraph

Article in Saudi medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Roaa S GassasFrom the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
Ahmed N AbsiFrom the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
Abdulrahman A AlghamdiFrom the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
Ahmed S AlsaeedFrom the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
Sameer M AlamoudiFrom the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
Ihab Y HemaidiFrom the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
Majed D AlahmadiFrom the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
Walaa A RajkhanFrom the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
Mannar M KhalilFrom the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
Saleem K DadahFrom the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
Ahmed S HigaziFrom the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
Amani S AhmedFrom the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess local epidemiology and risk factors for bacterial, fungal, and viral infections among the autologous bone marrow transplant population.

methodsThis study is a retrospective correlational cohort design comprising 150 adult patients who underwent autologous transplants at Princess Noorah Oncology Center, Jeddah, Saudi Arabia between 2014 and 2020.

resultsThe study findings indicate that bacterial infection prevalence differed significantly across the different disease status pre-salvage as patients with the relapsed disease were more likely to have bacterial infections. The median of engraftment days differed significantly between those who had a bacterial infection and those who did not. Interestingly, previous pneumonia infection had a positive relationship with the number of hospital stays.

conclusionsBacterial infections are the dominant type of infection among the autologous patient population. The research reflects authentic practice and reports unique characteristics of autologous transplant patients in terms of the prevalence and types of infection these patients experience.

Indexed as

Hematopoietic Stem Cell TransplantationVirus DiseasesBone Marrow TransplantationHumansRetrospective StudiesTransplantation, Autologousbone marrow transplantationinfectionlymphomamyelomarelapsed

Identifiers

PMID34344808
PMCPMC9195543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.